We are live on ! Find out more
RGC icon

Regencell Bioscience
RGC

5 hedge funds and large institutions have $281K invested in Regencell Bioscience in 2025 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 1

67% more funds holding

Funds holding: 3 → 5 (+2)

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

0.17% less ownership

Funds ownership: 0.24% → 0.07% (-0.17%)

46% less capital inflows, than outflows

Capital inflows: $90.1K | Capital outflows: $166K

Holders
5
Holders Change
+2
Holders Change %
+66.67%
% of All Funds
0.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
1
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Geode Capital Management
Geode Capital Management
Massachusetts
+$71.5K
2
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$10K
3
Tower Research Capital (TRC)
Tower Research Capital (TRC)
New York
+$7.33K
4
BlackRock
BlackRock
New York
+$1.31K

Top Sellers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
-$144K
2
Morgan Stanley
Morgan Stanley
New York
-$22K

RGC Hedge Fund Activity: Q1 2025 in Review

5 of the 7,487 institutional investors tracked by Wall St. Rank reported a position in Regencell Bioscience (RGC) for Q1 2025, worth a combined $281K — up 80% from $156K a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new RGC positions and 1 closed out — a net gain of 2 holders — while 1 added to existing stakes and 1 trimmed.

The largest buyer was Geode Capital Management, opening a new position worth an estimated $71.5K. The largest seller was UBS Group, exiting entirely with an estimated $144K sold.

  • 5 institutional investors held Regencell Bioscience (RGC) as of Q1 2025, up from 3 in Q4 2024.
  • Funds reported $281K of Regencell Bioscience stock for Q1 2025, up 80% quarter-over-quarter.
  • 3 funds opened new Regencell Bioscience positions in Q1 2025 and 1 closed out, a net change of +2 holders.
  • The largest Regencell Bioscience buyer in Q1 2025 was Geode Capital Management, an estimated $71.5K added.
  • The largest Regencell Bioscience seller in Q1 2025 was UBS Group, an estimated $144K sold.

Based on aggregated 13F filings for Q1 2025.